NeuroPace, Inc.
NPCENASDAQHealthcareMedical Devices

About NeuroPace

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Company Information

CEOJoel Becker
Founded1997
IPO DateApril 22, 2021
Employees184
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Phone650 237 2700
Address
455 North Bernardo Avenue Mountain View, California 94043 United States

Corporate Identifiers

CIK0001528287
CUSIP641288105
ISINUS6412881053
EIN22-3550230
SIC3841

Leadership Team & Key Executives

Joel D. Becker
Chief Executive Officer, President and Director
Dr. Martha J. Morrell M.D.
Chief Medical Officer
Rebecca L. Kuhn
Advisor
Patrick F. Williams
Chief Financial Officer
Dylan St. John
Chief of Operations and Development
Scott R. Schaper
Head of Investor Relations
Leah Akin
General Counsel and Corporate Secretary
Katie Keller
Vice President of Marketing
Chris Reese
Senior Vice President of Sales
Amy Treadwell
Vice President of Human Resources